Navigation Links
New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes

MILAN, Italy, June 15 /CNW/ - Today AMADEO, one of the first studies to compare the protective potential of two angiotensin receptor blockers in hypertensive patients with diabetic nephropathy, was presented at the European Society of Hypertension, Milan. The results from this study show that telmisartan reduces proteinuria to a significantly greater extent than losartan.(1)

Commenting on the results, Prof. Ellen Burgess, Foothills Hospital in Calgary, Canada said "The AMADEO results are encouraging for an increasing number of patients with type 2 diabetes because they suggest that telmisartan could improve renoprotection. It is particularly interesting that the observed effect was seen despite the study being controlled for blood pressure." She continued, "telmisartan has already shown superior blood pressure lowering compared to losartan and, in AMADEO, patients were allowed to take other medication, if needed, to ensure similar blood pressure in both treatment groups. This suggests that the protective benefits seen with telmisartan here are an additional attribute beyond its established blood pressure lowering effects."

Diabetic nephropathy is a kidney disease that occurs in approximately one third of patients with diabetes mellitus(2). These study results could, therefore, have a positive impact on millions of type 2 diabetes patients as well as healthcare systems worldwide. The prevalence of diabetes is projected to increase at an alarming rate from 171 million in 2000 to 366 million by 2030(3), with the upsurge in obesity closely linked to increased type 2 diabetes. Over time, diabetic nephropathy can lead to end-stage renal disease, a serious condition that needs dialysis and increased medical care and resources. End-stage renal disease has tripled in prevalence over the past two decades(4) and has huge associated healthcare costs, predicted to be US$28 billion by 2010 in the US alone(5).
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:
(Date:11/6/2009)... 6 Roper Industries, In...ed a definitive agreement to acquire Verathon, Inc...es. The Verathon Board of Directors has approved ...omary regulatory approvals and closing conditions,...ct the closing to be completed in early December. ...
(Date:11/6/2009)...PRNewswire-USNewswire/ -- America,s Specialty Medi...of mid-market and smaller innovator pharmaceutical...62, the "Affordable Health Care for America Act," ...e smaller companies fear that the cumulative effec... their efforts to bring new medicines to market. ...
(Date:11/6/2009)...RNewswire-FirstCall/ -- NuVasive, Inc. (Nasdaq: N...ing products for minimally disruptive surgical tre...ment of Michael J. Lambert as Executive Vice Presi...er 9, 2009. The Company also announced several ot...ael will be an excellent complement to the NuVasiv...
Breaking Medicine Technology:Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 2Roper Industries Announces Two Acquisitions to Enhance Growth in Medical and Toll & Traffic Businesses 3Statement of America's Specialty Medicines Companies On House Health Care Bill (H.R. 3962) 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 2NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 3NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 4NuVasive Appoints New Chief Financial Officer and Announces Additional Management Updates 5Nu Skin Celebrates Record Breaking Global Convention 60357 1Nu Skin Celebrates Record Breaking Global Convention 60357 2Nu Skin Celebrates Record Breaking Global Convention 60357 3Nu Skin Celebrates Record Breaking Global Convention 60357 4Nu Skin Celebrates Record Breaking Global Convention 60357 5Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 1Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 2Idenix Retains Worldwide Rights to Develop and Commercialize IDX184 for the Treatment of HCV 14655 3Cadence Pharmaceuticals to Host Conference Call and Webcast to Discuss Third Quarter 2009 Financial Results on November 5 2009 14653 1
(Date:11/8/2009)...ire-USNewswire/ -- Jon O,Brien, president of Catho...out the passage of HR 3962: ,, "Behavior in re...about core values. We in the prochoice community s... the struggles ordinary Americans have making ends...d basic healthcare or have to choose between maint...
(Date:11/8/2009)...demy of Health holds open house at Victoria campus...ovember 8, 2009 -- UCW Academy of Health invites a...a’s health care industry to attend their ope...9. , ,UCW Academy of Health, which offers diploma...ial services, designs its programs to meet the nee...
(Date:11/8/2009)...k called "Preventing and Healing AIDS Through...hows that AIDS is a result of multiple, repeated a...ne system stressor agents, which can be either che...ional. , Oakland, CA (PR...09, cell biologists, physicians, chemists and othe...
(Date:11/8/2009)...ire-USNewswire/ -- Today, the House of Representat... Smith, Ellsworth and Lipinski amendment to the "A.... The amendment maintains the current policy of pr...fits packages that include abortion. It clarifies ...lity credits and those who do not, can with their ...
(Date:11/8/2009)... H.R. 3961 to Secure the Stability of Medicare ,...tement Attributable to: J. James Rohack, M.D., Pre... http://www.newscom.com/cgi-bin/prnh/20081209/AM...House health reform bill, which will help improve ...calls for swift passage of H.R. 3961 to secure the...
Breaking Medicine News(10 mins):Health News:Catholics for Choice Statement on Healthcare Reform Bill 2Health News:College Invites Public to Explore Career Options in Health Care 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 2Health News:Revolutionary New Views on AIDS Highlight the Rethinking AIDS 2009 Congress; Emotional Issues can be a Significant Contributing Factor 3Health News:Family Research Council Praises Passage of Pro-life Amendment to Health Care Bill 2Health News:AMA Hails House Passage of Health Reform Bill (H.R. 3962) 2
...towards climate change, India will propose a dedic...to finance the development of clean energy techno...eveloping world. In a position paper on cl...gy-environment issues. "Due care must be t...
...earchers have found that a sugar supplement may he...ponsible for autoimmune diseases, such as multiple... attacking the body's tissues. Lead resear...ent taken by people with osteoarthritis that is kn...
...euronal mechanism that our brains may use to rapid...periences. The study, conducted by Univer...agues at the Massachusetts Institute of Technology...trouble distinguishing between separate but simila...
...via health scare in the West. Panic triggered off ...ptive efforts on a vast scale. In Canada after th...nation that is engaging the attention of the Ontar...y communities showed unacceptable levels of level....
...ortedly appear in a 50-minute talk and cookery dem...ie Show in London's Royal Horticultural Halls, lat...e of Beatles legend, Sir Paul McCartney, will foll...the animal rights activist have been sent out, and...
... researchers have opened up a new way to screen dr... develop new drugs. The Duke researches comp...eriments involving human cells and rats. The drugs...s of the study appear early online in the journal ...
Other Medicine News:Health News:India to Propose Global Fund for Clean Energy Technologies 2Health News:Sugar Supplement may Harbour Cure for Immune Diseases 2Health News:Why We Feel a Sense of Dj Vu 2Health News:Flush Water Pipes to Reduce Lead Contamination Risk, Schools Told 2Health News:Flush Water Pipes to Reduce Lead Contamination Risk, Schools Told 3Health News:Breast Cancer Drug Curbs Heart Disease. 2Health News:Breast Cancer Drug Curbs Heart Disease. 3
Penfield Dissector #3
Penfield Dissector #2
Leroy-Raney Scalp Clips
ScalpFix Scalp Clip System
Medicine Products: